» Articles » PMID: 33435197

Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls

Abstract

Although the etiology of multiple sclerosis (MS) is still unknown, it is commonly accepted that environmental factors could contribute to the disease. The objective of this study was to analyze the humoral response to Epstein-Barr virus, human herpesvirus 6A/B and cytomegalovirus, and the levels of 25-hydroxyvitamin D (25(OH)D) and the three main short-chain fatty acids (SCFA), propionate (PA), butyrate (BA) and acetate (AA), in MS patients and healthy controls (HC) to understand how they could contribute to the pathogenesis of the disease. With this purpose, we analyzed the correlations among them and with different clinical variables and a wide panel of cell subsets. We found statistically significant differences for most of the environmental factors analyzed when we compared MS patients and HC, supporting their possible involvement in the disease. The strongest correlations with the clinical variables and the cell subsets analyzed were found for 25(OH)D and SCFAs levels. A correlation was also found between 25(OH)D and PA/AA ratio, and the interaction between these factors negatively correlated with interleukin 17 (IL-17)-producing CD4+ and CD8+ T cells in untreated MS patients. Therapies that simultaneously increase vitamin D levels and modify the proportion of SCFA could be evaluated in the future.

Citing Articles

Pyroptosis the Emerging Link Between Gut Microbiota and Multiple Sclerosis.

Fan H, Shen R, Yan J, Bai Y, Fu Q, Shi X Drug Des Devel Ther. 2024; 18:6145-6164.

PMID: 39717200 PMC: 11665440. DOI: 10.2147/DDDT.S489454.


The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis.

Barcutean L, Maier S, Burai-Patrascu M, Farczadi L, Balasa R Int J Mol Sci. 2024; 25(6).

PMID: 38542172 PMC: 10970107. DOI: 10.3390/ijms25063198.


The role of short-chain fatty acids in central nervous system diseases: A bibliometric and visualized analysis with future directions.

Lan Z, Tang X, Lu M, Hu Z, Tang Z Heliyon. 2024; 10(4):e26377.

PMID: 38434086 PMC: 10906301. DOI: 10.1016/j.heliyon.2024.e26377.


Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.

Vojdani A, Vojdani E, Saidara E, Maes M Viruses. 2023; 15(2).

PMID: 36851614 PMC: 9967513. DOI: 10.3390/v15020400.


Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions.

Chen G, Shi F, Yin W, Guo Y, Liu A, Shuai J Front Microbiol. 2022; 13:916765.

PMID: 35966709 PMC: 9372561. DOI: 10.3389/fmicb.2022.916765.


References
1.
Lunemann J, Tintore M, Messmer B, Strowig T, Rovira A, Perkal H . Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol. 2010; 67(2):159-69. PMC: 2848293. DOI: 10.1002/ana.21886. View

2.
Ghareghani M, Reiter R, Zibara K, Farhadi N . Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway. Front Immunol. 2018; 9:2484. PMC: 6232868. DOI: 10.3389/fimmu.2018.02484. View

3.
Oliveira S, Simao A, Alfieri D, Flauzino T, Kallaur A, Mezzaroba L . Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress. J Neurol Sci. 2017; 381:213-219. DOI: 10.1016/j.jns.2017.07.046. View

4.
Kepczynska K, Zajda M, Lewandowski Z, Przedlacki J, Zakrzewska-Pniewska B . Bone metabolism and vitamin D status in patients with multiple sclerosis. Neurol Neurochir Pol. 2016; 50(4):251-7. DOI: 10.1016/j.pjnns.2016.04.010. View

5.
Makhani N, Banwell B, Tellier R, Yea C, McGovern S, OMahony J . Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination. Mult Scler. 2015; 22(3):385-8. DOI: 10.1177/1352458515595876. View